Climb Bio (CLYM)
NASDAQ:CLYM
US Market
Holding CLYM?
Track your performance easily

Climb Bio (CLYM) Technical Analysis

48 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
1Neutral
15Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Climb Bio’s (CLYM) Moving Averages Convergence Divergence (MACD) indicator is -0.59, suggesting Climb Bio is a Buy.
Climb Bio’s (CLYM) 20-Day exponential moving average is 4.31, while Climb Bio’s (CLYM) share price is $3.52, making it a Sell.
Climb Bio’s (CLYM) 50-Day exponential moving average is 5.26, while Climb Bio’s (CLYM) share price is $3.52, making it a Sell.

Climb Bio (CLYM) Pivot Points

Nov 08, 2024, 09:28 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.10
3.29
3.47
3.66
3.84
4.03
4.21
Fibonacci
3.29
3.43
3.52
3.66
3.80
3.89
4.03
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Climb Bio (CLYM) Moving Averages

Nov 08, 2024, 09:28 AM
Period
Simple
Exponential
MA5
3.62Sell
3.65Sell
MA10
3.83Sell
3.87Sell
MA20
4.40Sell
4.31Sell
MA50
5.77Sell
5.26Sell
MA100
6.43Sell
5.77Sell
MA200
5.62Sell
5.13Sell
Climb Bio’s (CLYM) 10-Day exponential moving average is 3.87, while Climb Bio’s (CLYM) share price is $3.52, making it a Sell.
Climb Bio’s (CLYM) 100-Day exponential moving average is 5.77, while Climb Bio’s (CLYM) share price is $3.52, making it a Sell.
Climb Bio’s (CLYM) stock price is $3.52 and Climb Bio’s (CLYM) 50-day simple moving average is 5.77, creating a Sell signal.
Climb Bio’s (CLYM) stock price is $3.52 and Climb Bio’s (CLYM) 100-day simple moving average is 6.43, creating a Sell signal.
Climb Bio’s (CLYM) stock price is $3.52 and Climb Bio’s (CLYM) 200-day simple moving average is 5.62, creating a Sell signal.

Climb Bio (CLYM) Technical Indicators

Nov 08, 2024, 09:28 AM
Name
Value
Implied Action
RSI (14)
23.24
Buy
STOCH (9,6)
14.79
Buy
STOCHRSI (14)
11.18
Buy
MACD (12,26)
-0.59
Buy
ADX (14)
35.20
Neutral
Williams %R
-93.08
Buy
CCI (14)
-103.78
Buy
ATR (14)
0.37
-
Ultimate Oscillator
24.98
Sell
ROC
-29.88
Sell
Climb Bio’s (CLYM) Relative Strength Index (RSI) is 23.24, creating a Buy signal.
Climb Bio’s (CLYM) Trend Strength Indicator (ADX) is 35.20, creating a Neutral signal.
Climb Bio’s (CLYM) Commodity Channel Index (CCI) is -103.78, creating a Buy signal.
Climb Bio’s (CLYM) Price Rate of Change (ROC) is -29.88, creating a Sell signal.

FAQ

Is CLYM a Buy, Hold, or Sell?
Based on CLYM’s technical indicators, CLYM is a Sell.
    What is CLYM’s RSI (14)?
    CLYM’s RSI (14) is 23.24, which suggests CLYM is a Buy.
      What is CLYM’s MACD?
      CLYM’s MACD is -0.59, which suggests CLYM is a Buy.
        What is CLYM’s 5-day moving average?
        CLYM’s 5-day moving average is 3.62, which suggests CLYM is a Sell.
          What is CLYM’s 20-day moving average?
          CLYM 20-day moving average is 4.40, which suggests CLYM is a Sell.
            What is CLYM’s 50-day moving average?
            CLYM’s 50-day moving average is 5.77, which suggests CLYM is a Sell.
              What is CLYM’s 200-day moving average?
              CLYM’s 200-day moving average is 5.62, which suggests CLYM is a Sell.
                What is CLYM’s Williams % R (14)?
                CLYM’s Williams % R (14) is -93.08, which suggests CLYM is a Buy.
                  What is CLYM’s CCI (14)?
                  CLYM’s CCI (14) is -103.78, which suggests CLYM is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis